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Background: Previous studies have reported a high prevalence of attention deficit
hyperactivity disorder (ADHD) among people living in detention (PLD) corresponding to a
five- to ten-fold increase compared to the general population. Our main study objective
was to provide an updated ADHD prevalence rate for PLD, including PLD in psychiatric
units. Sub-objectives included (i) comparing different ways of assessing ADHD, including
DSM-5 criteria and (ii) identifying which types of PLD are more likely to have ADHD.
Methods: We conducted a systematic review and meta-analysis following the PRISMA
guidelines and the MOOSE checklist. PubMed/Medline, PsycINFO, andWeb of Sciences
were searched combining “ADHD” and “prison” keywords and synonyms for articles
published between January 1, 1966 and January 2, 2018. Potential sources of variation
to the meta-analytic ADHD prevalence rate were investigated using meta-regressions
and subgroups analyses.
Results: The meta-analysis pooled 102 original studies including 69,997 participants.
The adult ADHD prevalence rate was 26.2% (95% confidence interval: 22.7–29.6).
Retrospective assessments of ADHD in childhood were associated with an increased
prevalence estimate (41.1, 95% confidence interval: 34.9–47.2, p < 0.001). There was
no significant difference in the prevalence estimate between screenings and clinical
interviews in adulthood. Only three studies used the DSM-5 definition of ADHD and
results were non-significantly different with other DSM versions. We found no difference
according to participants’ characteristics.
Conclusion: Our results confirmed the high prevalence rate of ADHD among PLD,
corresponding to a five-fold increase compared to the general population. In light of
such high ADHD prevalence, our results reinforce the importance of addressing this
critical public health issue by (i) systematically offering ADHD screening and diagnosis
to all individuals entering detention, and (ii) delivering treatment, monitoring, and care
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for ADHD during and after detention. These strategies may help reduce recidivism and
reincarceration, as well as violence in detention settings, in addition to improving the
health and wellbeing of people living in detention. Additionally, our study suggests that
using screening scales may be a reliable way of assessing ADHD, although caution is
needed because a complete evaluation by an experienced clinician is required to provide
a formal diagnosis.
Keywords: ADHD, incarceration, offender, prevalence, prison
INTRODUCTION
ADHD in the General Population
Attention deficit hyperactivity disorder (ADHD) is a disorder
characterized by difficulties paying attention, poor impulse
control, and hyperactive behaviors. ADHD starts in early
childhood and persists in adulthood in 40–60% of cases (1).
There is growing evidence that adult ADHD is a major health
concern (2). It is associated with at-risk behaviors and comorbid
psychiatric disorders (3) and affects several areas of life, such as
psychosocial functioning, school, work, and health care access
and health care use (4).
ADHD in Incarcerated Population
ADHD is associated with an increased risk of having judicial
contact at a younger age, including rule-breaking behaviors,
delinquency, criminality, and recidivism (5–7). ADHD seems
to be significantly more prevalent in incarcerated populations
in comparison with the general population and it has been
extensively studied in detention settings over the two last decades
(5). Compared with other offenders, incarcerated individuals
with ADHD are more likely to engage in misconduct in prison,
for example, be verbally and physically aggressive (8, 9), have
higher rates of recidivism (10), and have unsuccessful experiences
with the criminal justice system as well as with probation (11).
Therefore, ADHD seems to be a critical factor of the criminal
career (7), but further investigations are needed to understand
how ADHD is associated with involvement in the legal system.
To date, the only meta-analysis reporting ADHD prevalence
in incarcerated populations included studies published until
2012. The study identified a five- to ten-fold increase in
prevalence of ADHD compared to the general population (5):
25.5% compared to 5% in the general population (12–14).
Since 2012, several studies have investigated the prevalence
rates of ADHD in people living in detention (PLD) worldwide.
Additionally, this meta-analysis did not include PLD detained
in psychiatric units and therefore PLD with formal diagnostic
of comorbid psychiatric disorders were likely to be excluded. A
more complete picture of ADHD in prison setting is therefore
needed.
Measures of ADHD
ADHD was introduced for the first time in the second version of
the Diagnostic and Statistical Manual ofMental Disorders (DSM-
II), as “kyperkinetic disorder of childhood” (15). It emphasized
on hyperactivity as a cardinal feature of the disorder. In the
subsequent version of the DSM (DSM-III), the disorder was
labeled “Attention deficit disorder with or without hyperactivity”
(16). It emphasized on the attentional aspects of the disorder,
being considered as a tri-dimensional disorder. However,
subtypes were not considered. The main changes introduced in
the DSM-IV (17) were to label the disorder “ADHD” and to
define three subtypes (inattentive, hyperactive, and combined).
Then, two major changes in the diagnostic criteria for adult
ADHDwere introduced in the fifth version of the DSM (DSM-5),
which may affect the prevalence rate of ADHD (18). In the DSM-
5, there are a reduced number of symptoms for the diagnosis in
adults (five instead of six) and a later age of onset (twelve instead
of six) needed to diagnose ADHD. These changes to the DSM-IV
aim to address the restrictive diagnostic thresholds (19) and the
late onset of some symptoms that may occur in adulthood (20).
Recent studies concluded that the switch fromDSM-IV toDSM-5
diagnostic threshold resulted in a modest increase and less biased
ADHD prevalence rate (4, 21).
To date, no systematic review and meta-analysis has provided
an overview of how DSM-5 criteria may have affected the
prevalence rate of ADHD, especially among PLD. Furthermore, a
recent article questioned the reliability of ADHD prevalence rate
among PLD, as some major methodological shortcomings, such
as self-reported assessments or non-representative sampling,
may have resulted in high prevalence rates (22). Evidence
regarding the quality of ADHD studies in prison was therefore
needed.
Objective of the Study
This meta-analysis aimed to provide an updated estimate
the prevalence rate of ADHD in PLD over the past three
decades, including articles published since 2012. Sub-objectives
included (i) comparing different ways of assessing ADHD and
in particular investigating whether the DSM-5 resulted in an
increased prevalence rate of ADHD, and (ii) identifying which
characteristics of PLD were more likely to be associated with
ADHD (e.g., socio-demographics).
METHODS
The systematic review and meta-analysis adhered to the
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines (23) and the Meta-analysis of
Observational Studies in Epidemiology (MOOSE) checklist (24).
The protocol for this review was previously registered on
Prospero (CRD42017075510).
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Eligibility Criteria
All studies investigating ADHD in PLD were eligible for this
systematic review. In addition, articles were eligible if they (i)
reported an empirical study, (ii) were written in English, and (iii)
were published in a peer-reviewed journal.
Search Strategy
We searched Pubmed/Medline, PsycINFO, and Web of
Sciences from their inception date until January 2, 2018. We
used the terms “attention deficit hyperactivity disorder”
or “ADHD” and “prison” or “prisoner” or “inmate” or
“detaine∗” or “custod∗” or “detention” or “crim∗” or
“offend∗” or “correctional” or “forensic” or “penal institution.”
Published meta-analyses on the subject identified in the
search were hand-searched for other relevant studies using
their reference lists and studies quoting them. These meta-
analyses were excluded from the calculation of prevalence
estimates. Reference lists of retrieved studies were also
hand-searched.
Study Selection
After article duplicates were removed, a first round of selection
was performed to exclude studies meeting exclusion criteria
defined in the subsection Eligibility Criteria by screening titles
and abstracts, and, if necessary, the whole article. A second round
of selection was performed by reviewing the full text of articles.
We excluded articles reporting on the same dataset, articles
focusing only on participants with ADHD (100% prevalence
rate), articles reporting no prevalence rate (after unsuccessful
correspondence with the corresponding author), articles with
mixed prevalence rates for males and females, because gender
is known as an important predictor of ADHD (25) (for which
the corresponding author did not provide an answer regarding
separate prevalence rates), or if we were unable to access the
article.
Two rounds of reviewers (SB and AF/DG/MG) independently
screened all the abstracts in the first selection round. In case
of disagreement, consensus was achieved by discussion, and, if
required, by a third-party arbitration (HW).
Data Extraction
Characteristics of studies included in the meta-analysis were
extracted independently by two rounds of reviewers (SB and
EV/MG/NTT) using an electronic data abstraction form on
Excel. The form included the following study characteristics:
(1) year of publication (we used this information instead of
year of data collection because the latter was missing in 43.1%
of the studies); (2) geographic location; (3) sample size; (4)
study population (adults vs. youths); (5) type of detention
setting (prison, youth detention centers, or psychiatric unit);
(6) gender; (7) mean age; (8) presence of psychiatric disorders
in the sample (sample of psychiatric participants vs. “ordinary”
participants); (9) type of offenders (serious vs. non-serious
offenders; with “serious offending” defined in the corresponding
article as: violent or high-risk PLD, rapists, maximum-
security PLD, long-term sentences); (10) diagnostic tools
(self-reported screening for ADHD in adulthood/adolescence,
self-reported screening for ADHD in childhood, or clinical
interview), (11) criteria used for diagnosis (DSM-III, DSM-IV,
or DSM-5); and (12) ADHD prevalence rate. Mean age was
included for descriptive purposes. Studies involving both gender
and/or using different diagnostic criteria (e.g., a self-reported
assessment and a clinical interview) were recorded as separate
observations.
We contacted the authors of 67 articles regarding missing
information. Five authors answered but were unable to provide
gender-disaggregated prevalence rates, 35 provided missing
information, and 27 did not answer. Studies with missing
information on other variables than prevalence rates were kept
for descriptive purposes and to estimate the meta-analytic
prevalence rate of ADHD—this was not an exclusion criterion.
Listwise deletion was used for other analyses.
Risk of Bias Assessment
Articles included in the systematic review and meta-analysis
were assessed for the risk of bias using an adaptation of the
Quality in Prognosis Studies including the following relevant
items (26): (1) sample selection, (2) study participation, (3)
outcome measurement, and (4) presence of exclusion criteria.
Each study was rated as low, moderate, and high quality by two
rounds of reviewers (SB and EF/MG/TNT) (see Appendix 1 in
Supplementary Materials).
Statistical Analyses
We first undertook a descriptive analysis of the studies. We
then estimated the meta-analytic prevalence of ADHD. We
provided separate prevalence estimates for studies with an
adolescent/adult measure (screenings and clinical interviews)
and childhood measure. We also computed the prevalence
estimate for studies using clinical interviews, the most reliable
and valid way to assess ADHD. Indeed, screening tests are
not diagnostic tests (established using clinical interviews). They
are designed to detect people at risk for the corresponding
disease. Diagnostic tests establish the presence of the disease
and are used to determine the need for treatment (27, 28).
Finally, we tested potential influences of study characteristics.
Covariates were first tested using univariate meta-regressions,
and then simultaneously in a multivariate meta-regression
for all studies and for studies using clinical interviews. In
multivariate analyses, only factors with a sufficient number
of observations were included. As prison type was redundant
with study population and presence of psychiatric disorders, we
excluded it from the analyses. We used random-effects model
with restricted maximum-likelihood estimator (29) and the Knap
and Hartung method (30). We reported “variance accounted
for” (VAF) using a pseudo-R2. VAF is an indicator of effect
size and corresponds to the percentage of the heterogeneity in
the prevalence that is accounted for in each model. Analyses
were performed using R 3.4.3 and the package “metafor”
version 2.0.0.
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RESULTS
Study Selection
We identified 916 records on PubMed/Medline, psycINFO,
and Web of Sciences. After removal of 223 duplicates, 693
publications remained. We excluded 527 publications after a
first screening because they did not focus on ADHD in PLD
or did not report empirical findings. After further review of
the remaining 166 publications, 81 were excluded: 23 articles
did not report ADHD prevalence rates or gender-disaggregated
prevalence rates, 8 used samples composed of participants with
100% ADHD, 47 relied on data already used in other articles,
and 3 because we had no access to the full article. The manual
search of published meta-analyses led to the identification of
17 other studies. A total of 102 publications were included in
the meta-analysis (Figure 1). It led to 142 samples: 67 studies
with a single sample, 26 studies with both genders, 9 studies
with two assessment tools, one study with both genders and two
diagnostics, and one study with three diagnostics (one childhood
screening, one adulthood screening, and a clinical interview).
Data are reported in the Appendix 3. References for all studies
are reported in the Appendix 2.
Studies’ Characteristics
The meta-analysis pooled 102 original studies (142 samples),
including 69,997 participants (males: 89.0%; females: 11.0%;
adults: 27.5%, mean age = 32.7, range 24.8–44.9; youths: 72.5%,
mean age = 16.4, range 14.0–20.0). A total of 64.7% of the
studies were published in the 2008–2017 period, whereas 29.4%
FIGURE 1 | Flow diagram of study screening and inclusion process. PLD,
people living in detention.
were published between 1998 and 2007, and 4.9% between
1988 and 1997, plus one publication in 1985 (1.0%). The
25, 50, and 75th percentiles of year distribution corresponded
respectively to years 2004, 2010, and 2014. Data came from
28 countries distributed as follows: Europe (49.0%, n = 67),
North America (35.3%, n = 53), Asia (6.9%, n = 8), Australia
(4.9%, n = 9), and South America (3.9%, n = 5). The
information on the number of studies included for each region
and other characteristics are reported in the first column
of in Table 1. Most studies used a clinical diagnosis (58.5%,
n = 83), while 21.1% (n = 30) used self-reported screenings of
childhood ADHD and 20.4% (n= 29) self-reported screenings of
adolescent/adult ADHD. A total of 16.2% (n = 23; total number
of participants = 2,321, not shown in Table 1) of the studies
focused on samples of participants with a psychiatric diagnosis
other than ADHD (for example, participants with conduct or
personality disorders, schizophrenia, or referred for psychiatric
assessment), and 15.5% on serious offenders (n = 22; total
number of participants=15,360, not shown in Table 1). Overall,
the quality of the studies was high. There was 23.2% (n = 33)
of studies with a “weak” quality: in total, 13.4% had a response
rate ≤60% or a convenient sample, 24.7% excluded non-native
speakers, and 16.2% excluded PLD with psychiatric or somatic
disorders (e.g., psychotic symptoms, presence of severe mental
disorder, or physical illness, but of course participants with
ADHD symptoms were not excluded) (not shown in Table 1).
Overall Prevalence Rate of ADHD
The ADHD adolescent/adult meta-analytic prevalence estimate
was 26.2% [95% confidence interval (CI): 22.7–29.6]. The
childhood ADHD meta-analytic prevalence estimate assessed
retrospectively in adolescence/adulthood was 41.1% (95% CI:
34.9–47.2). Data based on clinical interviews (83 study samples)
showed an overall prevalence estimate of 26.7% (95% CI: 22.7–
30.7). Prevalence estimates for all study samples according to the
year of publication are reported in Figure 2.
Factors Related to ADHD Prevalence
Estimate
Results of meta-regressions for all studies (n = 142 samples)
are reported in Table 1. Only one covariate was significantly
associated with heterogeneity of prevalence estimates. Screenings
of childhood ADHD were associated with an increased
prevalence rate compared to current diagnosis using clinical
interviews (i.e., for the univariate model: respectively b = 0.28,
which correspond to a prevalence estimate of 28% and b = 0.15,
which corresponded to a prevalence estimate of 0.28 +
0.15 = 43%, p < 0.001) or screening of adolescent/adult ADHD
(univariate and multivariate models: estimate = 0.17, p < 0.001,
not shown in Table 1). For the diagnosis of adolescent/adult
ADHD, there was no difference between clinical interviews and
screenings (p ≥ 0.574).
When pooling only articles using diagnostic interviews
(n = 83), the results were almost similar, with no covariate
reaching the significance level (Table 2). For models with
significant predictors, the VAF remained small (VAF≤ 10.3%).
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TABLE 1 | Univariate and multivariate meta-regressions for all study samples (n = 142).
No. of study samples Univariate models Multivariate model
Estimate p-value VAF% Estimate p-value VAF5
Intercept − – – – 0.23 <0.001 7.8
Region
North America (reference) 53 0.29 <0.001 1.5 – –
Asia 8 0.07 0.331 – –
Australia 9 −0.07 0.307 – –
Europe 67 0.03 0.453 – –
South America 5 −0.14 0.113 – –
Gender
Male (reference) 104 0.30 <0.001 0.0 – –
Female 38 −0.01 0.768 −0.01 0.901
Study population
Adults (reference) 77 0.31 <0.001 0.0 – –
Youths 65 −0.01 0.694 0.03 0.340
Psychiatric diagnosis
No (reference) 119 0.29 <0.001 0.0 – –
Yes 23 0.04 0.340 0.05 0.228
Serious offenders
No (reference) 120 0.30 <0.001 0.0 – –
Yes 22 −0.01 0.803 −0.01 0.778
Diagnostic
Interview (reference) 83 0.28 <0.001 10.3 – –
Current screening 29 −0.03 0.574 −0.01 0.924
Retrospective screening 30 0.15 <0.001 0.16 0.003
DSM Version
DSM-IV (reference) 112 0.29 <0.001 0.0 – –
DSM-III 18 0.02 0.618 – –
DSM-5 5 0.08 0.484 – –
Quality
Strong (reference) 57 0.27 <0.001 0.5 – –
Moderate 52 0.04 0.328 0.01 0.950
Weak 33 0.06 0.138 0.02 0.662
VAF, Variance accounted for (pseudo-R2 ).
Significant and marginally significant results are in bold.
DISCUSSION
ADHD Prevalence Rate Among People
Living in Detention
This study updated the prevalence rate of ADHD in prison
settings (including PLD detained in psychiatric units). We
identified 102 studies meeting study criteria (142 study samples)
published from 1985 to 2017 with data collected in 28 countries.
The pooling of all studies yielded an adolescent/adult ADHD
prevalence rate of 26.2%, while the pooling of only those using
clinical interviews found a similar rate of 26.7%. This high
ADHD prevalence rate corresponds with a five-fold increase in
comparison with that of the general population (12–14). These
findings are consistent with those of Young et al’s earlier meta-
analysis (31) and added more evidence for the relationship
between ADHD and involvement in the legal system.
By contrast, the retrospective assessment of ADHD in
childhood was higher at 41.1%. This suggests a remission rate
of 63.8%, although a study with a longitudinal design would be
required to definitively confirm this. Nevertheless, the estimation
corresponds to data obtained from the general population
reporting remission in 40–60% of cases (1).
These results suggest that PLD bear a heavy mental health
burden on secure services as around one-third may require
treatment for ADHD. PLD with ADHD should be referred
to mental health services, not only to confer personal health
and well-being, but because treatment may support them in
their interface and progress within the criminal justice system
(6, 11). Several studies have reported the efficacy and safety of
pharmacotherapy for ADHD during adulthood, also in prison
(32–35). These studies reported strong treatment effects with
positive outcomes (e.g., reduction in the symptomatology of
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FIGURE 2 | ADHD prevalence estimates according to publication year. The point sizes correspond to the standard error (a larger size indicates a higher error).
ADHD over time, no drug abuse during the study, increase in
psychosocial outcome). Most of the studies included in our meta-
analysis did not report ADHD treatment. Therefore, intervention
studies to treat ADHD in prison are needed in addition to
screening and diagnostic studies.
Furthermore, the meta-analysis of Young et al. (36) reported
that PLD with ADHD (compared with those without ADHD)
had significantly higher rates of mood disorder in youth
institutions and those in adult institutions presented with
significantly higher rates of conduct disorder in childhood,
anxiety, mood, personality, and substance use disorders. Hence,
they are individuals with a higher rate of comorbidity. Even if
some specific psychological interventions have been developed
for youths and adults with ADHD [e.g., (31, 37, 38)], there is
a dearth of data on both pharmacological and psychological
intervention for people with ADHD in the criminal justice system
and this should be investigated as a priority, given the high
prevalence of ADHD in detainees.
Comparing ADHD Assessments
Our study results are influenced by the methods used to ascertain
ADHD. Screenings for ADHD in childhood were associated with
increased prevalence estimates in comparison with evaluation
of adolescent/adult ADHD (using clinical interviews and self-
reported screenings). Previous studies already demonstrated that
methods have an effect on the prevalence estimate (5, 12). This
result was probably due to the fact that some participants were in
remission from ADHD (39, 40). Consequently, prevalence rates
for childhood and adult ADHD should not be grouped together.
Attention should be given to the kind of assessment used to
estimate the prevalence rate of ADHD when interpreting the
data.
Prevalence estimates pooled from studies using screenings for
adolescence/adult ADHD were not significantly different from
estimates of studies using clinical interviews. Recent studies
showed that self-reported assessments of ADHD in adulthood are
reliable [for example, the ADHD self-reported screening scale,
ASRS, (41): sensitivity = 91.4%, specificity = 96.0%; the Barkley
screen (B-BAARS) (42): sensitivity = 84%, specificity = 82%].
Our results suggest the same conclusions. Using self-reported
screening may be a reliable way of assessing adult ADHD,
although caution is needed because a complete evaluation by an
experienced clinician is required to provide a formal diagnosis.
Clinical interviews may also find psychiatric comorbid states.
To our knowledge, no meta-analysis has investigated
differences in estimates according to DSM versions, including
the DSM-5. Unfortunately, there were only three studies using
the DSM-5 version to assess ADHD among PLD. There was no
significant difference between the versions of DSM, but there
was probably a bias due to a lack of statistical power. Further
studies should test whether there is an increase in the prevalence
rate of ADHD when the DSM-5 definition is used (4, 21). We
recommend that all future studies use the DSM-5 to provide
unbiased prevalence rates of ADHD (41).
From a methodological point of view, the quality of the
studies did not significantly affect the prevalence estimates of
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TABLE 2 | Univariate and multivariate meta-regressions for study samples with clinical interviews (n = 83).
No. of study samples Univariate models Multivariate model
Estimate p-value VAF% Estimate p-value VAF%
Intercept − – – – 0.20 <0.001 3.5
Region
North America (reference) 40 0.27 <0.001 2.4 – –
Asia 7 0.10 0.203 – –
Australia 4 −0.15 0.115 – –
Europe 32 0.02 0.600 – –
South America 0 – – – –
Gender
Male (reference) 59 0.27 <0.001 0.0 – –
Female 24 −0.01 0.949 0.01 0.896
Study population
Adults (reference) 28 0.22 <0.001 2.2 – –
Youths 55 0.06 0.133 0.07 0.105
Psychiatric diagnosis
No (reference) 63 0.25 <0.001 2.3 – –
Yes 20 0.09 0.073 0.09 0.057
Serious offenders
No (reference) 71 0.27 <0.001 0.0 – –
Yes 12 −0.05 0.361 −0.05 0.433
DSM Version
DSM-IV (reference) 65 0.26 <0.001 0.0 – –
DSM-III 10 −0.02 0.718 – –
DSM-5 3 0.11 0.331 – –
Quality
Strong (reference) 54 0.26 <0.001 0.0 – –
Moderate 25 0.04 0.339 – –
Weak 4 −0.05 0.676 – –
VAF, Variance accounted for (pseudo-R2 ).
Significant results are in bold.
ADHD (presence of exclusion criteria, high non-response rate,
or convenient samples, and use of self-reported screenings).
Previous studies criticized methodological weaknesses in many
prison (22, 43). However, our meta-analysis pooled studies
of generally high quality that used reliable and valid ADHD
diagnostic approaches as well as robust methods altogether
agreeing a high ADHD prevalence estimate.
ADHD According to Participant
Characteristics
One of our sub-objectives was to identify which characteristics of
PLD were associated with ADHD. Among the five characteristics
included in our meta-analysis, none was associated with a
significant increase in the ADHD prevalence rate.
Although ADHD is highly comorbid with other psychiatric
disorders (36, 44), we did not identify a significant increase of
ADHD among PLD with a comorbid diagnostic. In incarcerated
populations, Young et al. (36) reported that several psychiatric
disorders co-occur with an ADHD diagnostic in PLD, including
conduct disorder, substance use disorder, mood disorder,
depressive disorder, anxiety disorder, and personality disorder. In
our study, “PLD having a psychiatric disorder” included a large
range of disorders (conduct disorder, substance use disorder,
mood disorder, and personality disorder). Our non-significant
result might suggest that PLD without a formal diagnosis of
comorbid disorders, not detained in psychiatric units or who
have not been referred for psychiatric forensic investigation
may in fact also have psychiatric comorbidities. This would in
turn suggests that PLD are a highly comorbid population as
a whole and that attention should be given to ADHD even if
no other formal diagnosis exists. Another explanation was that
ADHD is comorbid with some specific disorders (e.g., substance
use disorders or antisocial personality disorder). Theses specific
features have been missed since the comorbidity group included
all psychiatric conditions in a general way.
There were no significant differences for gender and age
(adults vs. youths). This supported the previous meta-analysis of
Young et al. (5) conducted on a prison population and contrasted
with findings from the general population (reporting higher
prevalence of ADHD amongst males and youths). Regarding
gender, a previous study reported that the prevalence rate ranges
from 2.1 to 5.4% among males and 1.1 to 3.2% among females,
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but females were more likely to have persistent ADHD in
adulthood (45). However, this narrative review reported that
gender differences may be partially due to methodological bias
rather than fundamental differences in the expression of ADHD.
For example, males may be over-referred and over-diagnosed in
comparison with females (45–47). This referral bias is lost with
offenders, because female offenders become noticed due to their
offending. Another explanation is the 8:1 ratio of males to females
living in detentionmaymean that females benefit from protective
measures that keep them out of detention (5). Female offenders
are therefore likely to be more serious cases with a high rate of
psychiatric disorders, including ADHD, in comparison withmale
offenders (48, 49).
Regarding population age, studies have reported that full
remission of childhood ADHD commonly occurred in adulthood
after brain maturation (39, 40). However, we did not find
any difference between adolescents (mean age = 16.2) and
adults. The higher prevalence rates for childhood prevalence in
comparison with adolescence/adulthood prevalence may be due
to the remission between childhood and adulthood. Another
explanation may be that young offenders with ADHD are
diverted out of the criminal justice system and referred early
on to psychiatric outpatient clinics or adapted residential homes
(5). Further, adults with ADHD may be over-represented in
prison settings in comparison with the general population,
because ADHD symptoms is associated with an increased risk of
offending (5–7).
LIMITATIONS
Only methodological and PLD characteristics that were available
across studies, or in most studies, were included. This may
have led us to miss some important factors associated with
the heterogeneity of study findings. For example, we were
unable to extract precisely the type of detention (e.g., pre-trial,
post-trial, high-security prison). Most studies did not report
ADHD treatment, whichmay have been helpful in understanding
ADHD remission. Second, the validity and reliability of ADHD
assessments may have contributed to the heterogeneity of the
prevalence estimates. However, our meta-analysis took into
account the overall diagnostic approach, even if the specific
characteristics of the assessment scales were not included in the
model. The heterogeneity of the samples used was also a possible
source of variability in the prevalence estimates. This was taken
into account by using random study effects. Finally, there were
insufficient studies applying the DSM-5 definition of ADHD for
meaningful analysis and some regions of the world were under-
represented (South America), whereas other were completely
missing (e.g., Africa).
CONCLUSION
ADHD has been an important research focus in the last 2
decades, with 102 studies published in 28 countries regarding
prevalence in prison settings around the world. In light of
the high ADHD prevalence among PLD (including PLD with
comorbid disorders incarcerated in psychiatric units), a five-
fold increase in comparison with the general population, our
results reinforce the importance of addressing this critical public
health issue by (i) systematically offering ADHD screening and
diagnosis to all individuals entering detention (youths, adults,
men, women) following the most up-to-date criteria, and (ii)
delivering treatment, monitoring, and care for ADHD and other
psychiatric comorbidities to patients while they are in prison and
after their release. These strategies may benefit PLD, prison staff,
and society in general. Further studies should research the needs
of this population and investigate the efficacy and effectiveness of
treatment (both pharmacological and psychological) for PDL
with ADHD are required.
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